News | May 21, 2010

Delivery System Makes for More Precise Stent Placement


May 21, 2010 – A new stent delivery system is designed to be reliable, easy to use and precise when delivering the self-expanding Supera peripheral vascular stent. The new delivery system was launched this week in Europe.

The Supera Veritas system was developed to deliver the Supera for the treatment of biliary and peripheral artery disease (PAD).

“We have been utilizing the Supera stent clinically for more than two years and we are very impressed with the performance of the stent and positive clinical outcomes,” said Dierk Scheinert, M.D., chairman of the Center for Vascular Medicine at the Park Hospital Leipzig, Germany. "With the new Supera Vertas delivery system, we now have a more effective tool for the smooth and controlled deployment of the Supera stent. It significantly reduces the number of steps needed to prep and deliver the stent, all of which greatly increase its ease of use and accuracy.”

The IDEV Inc. expects to introduce two additional products in its family of Supera stents by the end of this year. The stent uses an interwoven self-expanding nitinol design. It has U.S. Food and Drug Administration (FDA) 510(k) clearance for palliative treatment for biliary strictures produced by malignant neoplasms. It is currently the focus of a prospective, FDA-approved, single-arm clinical trial of 258 patients at up to 40 sites in the United States.

For more information: www.idevtechnologies.com


Related Content

News | Stents

July 5, 2022 — A BIO-RESORT subgroup analysis of outcomes in small coronary vessels (<2,5mm) evaluated the efficacy and ...

Home July 05, 2022
Home
News | Stents

June 2, 2022 — According to the U.S. Food and Drug Administration (FDA), Atrium Medical Corporation is recalling the ...

Home June 02, 2022
Home
News | Stents

May 13, 2022 — Vascular diseases are public enemy number one: the leading killers worldwide, accounting for nearly a ...

Home May 13, 2022
Home
News | Stents

April 6, 2022 – Narrowed arteries can restrict blood flow to the heart. One treatment is inserting a stent — a small ...

Home April 06, 2022
Home
News | Stents

November 9, 2021 — Results from SUGAR trial, a randomized, controlled, multicenter trial conducted exclusively in ...

Home November 09, 2021
Home
News | Stents

June 30, 2021 — Abbott announced its Xience family of drug-eluting coronary stents received U.S. Food and Drug ...

Home June 30, 2021
Home
News | Stents

April, 14, 2021 – Elixir Medical recently announced the first patient was treated in the BIOADAPTOR randomized ...

Home April 14, 2021
Home
News | Stents

April 6, 2021 — Abbott today announced its Xience stent has received CE mark in Europe for shorter duration of dual anti ...

Home April 06, 2021
Home
News | Stents

December 21, 2020 – A proposed ASTM International standard will answer the need for a standardized test method that ...

Home December 21, 2020
Home
News | Stents

November 24, 2020 — One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT ...

Home November 24, 2020
Home
Subscribe Now